2025 · 2nd Quarter (Apr 1 - June 30)

PLASMA PROTEIN THERAPEUTICS ASSOCIATION

Filed by WILLIAMS AND JENSEN, PLLC.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 18, 2025
Income: $50,000.00
Expenses: Not reported
Registrant: WILLIAMS AND JENSEN, PLLC
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Filing UUID: 9a2a1d8f-aa0a-4bf9-adb4-d3ce9bc8edf6
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Literal federal measure citations: H.R. 1

HCR · Health Issues

Matters affecting plasma donation and potential plasma shortages. Issues related to PAHPA.

TAX · Taxation/Internal Revenue Code

Tax legislation affecting the Orphan Drug Tax Credit and the Research and Development Tax Credit.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.